Vertex Pharmaceuticals (VRTX) EBT Margin (2009 - 2026)
Vertex Pharmaceuticals (VRTX) posted quarterly EBT Margin of 41.95% for Q1 2026, up 1558.0% year-over-year from 2.53% in Q1 2025, and up 0.53% quarter-over-quarter from 41.72% in Q4 2025.
Vertex Pharmaceuticals (VRTX) EBT Margin (2009 - 2026) Analysis & Trends
Vertex Pharmaceuticals' EBT Margin history runs 18 years deep, the most recent figure standing at 41.95% for Q1 2026.
- In Q1 2026, EBT Margin rose 1558.0% year-over-year to 41.95%; the TTM figure through Mar 2026 stood at 42.28% (up 4498.0% YoY), while the FY2025 annual figure was 38.69%, up 3643.0% from the prior year.
- EBT Margin for Q1 2026 stood at 41.95%, up from 41.72% in the prior quarter.
- The five-year high for EBT Margin was 50.4% in Q3 2022, with the low at 128.18% in Q2 2024.
- The 5-year median for EBT Margin is 44.16% (2024), against an average of 33.21%.
- The sharpest annual moves came in 2024 and 2025: EBT Margin tumbled 17477 bps in 2024, then jumped 17146 bps in 2025.
- Vertex Pharmaceuticals' EBT Margin stood at 46.76% in 2022, then fell by 3 bps to 45.58% in 2023, then dropped by 14 bps to 39.03% in 2024, then climbed by 7 bps to 41.72% in 2025, then gained by 1 bps to 41.95% in 2026.
- Business Quant data shows VRTX's EBT Margin at 41.95% in Q1 2026, 41.72% in Q4 2025, and 42.22% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 41.75% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 35.61% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 34.77% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 18.33% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -94.22% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 12.09% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.77% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -2.67% |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | -20,427.46% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 41.75% |
| Mar 31, 2026 | 41.95% |
| Dec 31, 2025 | 41.72% |
| Sep 30, 2025 | 42.22% |
| Jun 30, 2025 | 43.28% |
| Mar 31, 2025 | 26.37% |
| Dec 31, 2024 | 39.03% |
| Sep 30, 2024 | 44.16% |
| Jun 30, 2024 | -128.18% |
| Mar 31, 2024 | 47.54% |
| Dec 31, 2023 | 45.58% |
| Sep 30, 2023 | 47.48% |
| Jun 30, 2023 | 46.59% |
| Mar 31, 2023 | 37.54% |
| Dec 31, 2022 | 46.76% |
| Sep 30, 2022 | 50.40% |
| Jun 30, 2022 | 46.64% |
| Mar 31, 2022 | 45.52% |
| Dec 31, 2021 | 42.02% |
| Sep 30, 2021 | 54.57% |